4 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 6 Phase 2, 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Terminated 1 |
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Darbepoetin: new trials by email Literature Review of Darbepoetin trials Research Report on Darbepoetin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis Gcsf, Darbepoetin, Standard Medical Treatment - Decompensated Cirrhosis | Not applicable | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 110 | 2025-09-01 | 2025-08-20 |
| Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis. Darbepoetin, G-CSF, Lactulose - Decompensated Liver Cirrhosis | Not applicable | Recruiting | Institute of Liver and Biliary Sciences, India | 60 | 2025-06-04 | 2026-05-22 |
| Mechanisms of EPO-induced Hypertension Darbepoetin - Chronic Kidney Disease, Blood Pressure | Phase 2 | Terminated | VA Office of Research and Development | 27 | 2021-01-04 | 2025-12-15 |
| Mild Encephalopathy in the Newborn Treated With Darbepoetin Darbepoetin Alfa, Normal Saline - Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy Mild | Phase 2 | Completed | University of New Mexico | 28 | 2017-12-01 | 2023-12-21 |
| Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants Darbepoetin, Placebo - Neurocognitive, Neuroprotective | Phase 3 | Completed | NICHD Neonatal Research Network | 650 | 2017-09-20 | 2026-07-01 |
| Long-term Pre-dialysis Extension in Europe and Asia Pacific Molidustat (BAY85-3934), Darbepoetin - Anemia, Renal Insufficiency, Chronic | Phase 2 | Completed | Bayer | 166 | 2014-06-24 | 2017-11-22 |
| Darbepoetin Alpha in Myelodysplastic Syndromes (MDS) Darbepoetin - Myelodysplastic Syndromes | Phase 2 | Unknown | Groupe Francophone des Myelodysplasies | 99 | 2006-12-01 | 2007-05-17 |
| Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS) Darbepoetin and Filgrastim, Darbepoetin - Myelodysplastic Syndromes | Phase 2 / Phase 3 | Unknown | St. Bartholomew's Hospital | 360 | 2004-10-01 | 2009-03-12 |
| Study of Aranesp to Treat Anemia in Prostate Cancer Patients. Aranesp - Prostate Cancer, Anemia | Phase 2 | Completed | University of Washington | 20 | 2003-04-01 | 2007-11-29 |
Anemia (4) · Myelodysplastic Syndromes (2) · Renal Insufficiency, Chronic (2) · Brain Diseases (1) · Prostatic Neoplasms (1)
Institute of Liver and Biliary Sciences, India (2) · Bayer (1) · Groupe Francophone des Myelodysplasies (1) · NICHD Neonatal Research Network (1) · St. Bartholomew's Hospital (1) · University of New Mexico (1) · University of Washington (1) · VA Office of Research and Development (1)
United States (4) · France (2) · India (2) · United Kingdom (2) · Australia (1) · Bulgaria (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Poland (1) · Romania (1) · South Korea (1) · Spain (1)
Celestia S Higano, MD (1) · Dr Manoj Kumar Sharma, DM (1) · Dr. Shiv Kumar Sarin, DM (1) · Rajiv Agarwal, MD MBBS (1) · Robin Ohls, MD (1) · Samir G Agrawal, MD, PhD (1) · Tara L DuPont, MD (1) · Tomasz M Beer, MD (1)
PMID 23358617, PMID 33432157, PMID 37596391, PMID 38227447, PMID 40354084, PMID 41392547